Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003.
Schreiber S, Campieri M, Colombel JF, van Deventer SJ, Feagan B, Fedorak R, Forbes A, Gassull M, Gendre JP, van Hogezand RA, Lofberg R, Modigliani R, Pallone F, Petritsch W, Prantera C, Rampton D, Seibold F, Vatn M, Zeitz M, Rutgeerts P; BMBF Competence Network "Inflammatory Bowel disease". Schreiber S, et al. Among authors: petritsch w. Int J Colorectal Dis. 2001 Feb;16(1):1-11; discussion 12-3. doi: 10.1007/s003840100285. Int J Colorectal Dis. 2001. PMID: 11317691
[Ustekinumab - Current position].
Siegmund B, Högenauer C, Novacek G, Petritsch W, Reinisch W, Schoepfer A, Schreiber S, Vavricka S, Bokemeyer B; für die IBD-Dach-Gruppe. Siegmund B, et al. Among authors: petritsch w. Z Gastroenterol. 2018 Sep;56(9):1077-1086. doi: 10.1055/a-0655-2425. Epub 2018 Aug 13. Z Gastroenterol. 2018. PMID: 30103222 Review. German.
Mycophenolate mofetil in Crohn's disease.
Rampton DS, Neurath MF, Almer S, D'Haens G, Petritsch W, Stange EF. Rampton DS, et al. Among authors: petritsch w. Lancet. 2000 Jul 8;356(9224):163-4. doi: 10.1016/s0140-6736(05)73176-7. Lancet. 2000. PMID: 10963270 Clinical Trial. No abstract available.
6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.
de Boer NK, Reinisch W, Teml A, van Bodegraven AA, Schwab M, Lukas M, Ochsenkühn T, Petritsch W, Knoflach P, Almer S, van der Merwe SW, Herrlinger KR, Seiderer J, Vogelsang H, Mulder CJ; Dutch 6-TG working group. de Boer NK, et al. Among authors: petritsch w. Digestion. 2006;73(1):25-31. doi: 10.1159/000091662. Epub 2006 Feb 21. Digestion. 2006. PMID: 16493198 Free article. Review.
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.
Miehsler W, Novacek G, Wenzl H, Vogelsang H, Knoflach P, Kaser A, Dejaco C, Petritsch W, Kapitan M, Maier H, Graninger W, Tilg H, Reinisch W; Austrian Society of Gastroenterology and Hepatology. Miehsler W, et al. Among authors: petritsch w. J Crohns Colitis. 2010 Sep;4(3):221-56. doi: 10.1016/j.crohns.2009.12.001. Epub 2010 Mar 17. J Crohns Colitis. 2010. PMID: 21122513
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C, Petritsch W; Austrian Inflammatory Bowel Diseases Study Group. Gasche C, et al. Among authors: petritsch w. Am J Gastroenterol. 2001 Aug;96(8):2382-7. doi: 10.1111/j.1572-0241.2001.04094.x. Am J Gastroenterol. 2001. PMID: 11513178 Clinical Trial.
[Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
Dejaco C, Haas T, Kirchgatterer A, Miehsler W, Wenzl H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W, Tilg H. Dejaco C, et al. Among authors: petritsch w. Z Gastroenterol. 2006 Jun;44(6):525-38; discussion 539. doi: 10.1055/s-2006-926796. Z Gastroenterol. 2006. PMID: 16773519 Review. German.
91 results